Activation of G protein-coupled receptors (GPCRs) leads to the dissociation of heterotrimeric G-proteins into Gα and Gβγ subunits, which go on to regulate various effectors involved in a panoply of cellular responses. During chemotaxis, Gβγ subunits regulate actin assembly and migration, but the protein(s) linking Gβγ to the actin cytoskeleton remains unknown. Here, we identified a Gβγ effector, ElmoE in Dictyostelium, and demonstrated that it is required for GPCR-mediated chemotaxis. Remarkably, ElmoE associates with Gβγ and Dock-like proteins to activate the small GTPase Rac, in a GPCR-dependent manner, and also associates with Arp2/3 complex and F-actin. Thus, ElmoE serves as a link between chemoattractant GPCRs, G-proteins and the actin cytoskeleton. The pathway, consisting of GPCR, Gβγ, Elmo/Dock, Rac, and Arp2/3, spatially guides the growth of dendritic actin networks in pseudopods of eukaryotic cells during chemotaxis.

SummaryTheabilityofcells to senseexternalchemical cues and respond by directionallym igrating towards them is af undamental process called chemotaxis. This phenomenon is essentialf or many biologicalresponses in the human body, including the invasion of neutrophils to siteso fi nflammation.Remarkably, manyo ft he molecularmechanisms involved in controlling neutrophils chemotaxis arose millionsofyears agointhe simple eukaryotic organism Dictyosteliumdiscoideum.Both neutrophils and DictyosteKeywords Dictyostelium, neutrophils,chemotacticsignaling lium use Gp rotein-coupleds ignaling cascades to mediate chemotacticr esponses,which arer esponsible fort ransducinge xternalc uesi nto highlyo rganized cytoskeletal rearrangements that ultimatelyl eadt od irectedm igration. By using the geneticallya nd biochemically tractable organism Dictyostelium as a modelsystem,ithas been possible to decipher manyofthe signal transduction events that areinvolved in chemotaxis.

Familial hypercholesterolemia (FH) is a common, autosomal dominant disorder of lipid metabolism, caused by defects in the receptor-mediated uptake of LDL (low-density lipoproteins) due to mutations in the LDL receptor gene (LDLR). Mutations underlying FH in Bulgaria are largely unknown. The aim of the present study was to provide information about the spectrum of point mutations in LDLR in a sample of 45 Bulgarian patients with severe hypercholesterolemia. Exons 3, 4, 6, 8, 9, and 14, previously shown to be mutational hot spots in LDLR, were screened using PCR-single-strand conformation polymorphism (SSCP). Samples with abnormal SSCP patterns were sequenced. Three different, hitherto undescribed point mutations (367T>A, 377T>A, 917C>A) and two previously described mutations (858C>A and 1301C>T) in eight unrelated patients were identified; four of the detected point mutations being missense mutations and one, a nonsense mutation. One of the newly described point mutations (917C>A) is a base substitution at a nucleotide position, at which two other different base substitutions have already been reported. Thus, all three possible base substitutions at this nucleotide position have been detected, making it a hot spot for point mutations causing FH. This is the first such mutational hot spot described in exon 6 of LDLR.